Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cambrian BioPharma

Request full access

Biotechnology company developing transformative medicines for aging-related diseases

New York City, United StatesFounded 2019Biotech & Life Sciences

About Cambrian BioPharma

Cambrian Bio is a pioneering startup in the healthcare sector, focusing on the development of innovative medicines aimed at extending the healthspan - the period of life spent in good health. The company operates at the intersection of biomedicine and data science, using a data-driven approach to create a pipeline of therapies that could potentially redefine healthcare in the 21st century.

The company's primary clients are patients in need of new classes of medicines. These medicines are designed to understand and target the biological drivers of aging, with the potential to treat and prevent some of today's deadliest diseases. By partnering with exceptional scientists, Cambrian Bio is able to bring a fresh perspective and innovative solutions to the healthcare market.

Cambrian Bio's business model is centered around the development and distribution of these transformative therapies. The company makes money by creating effective and safe therapies and making them widely available to patients. This is achieved through rigorous scientific research and a bold mission to extend healthspan.

In summary, Cambrian Bio is a forward-thinking biomedicine company, using data-driven approaches to develop therapies that aim to extend the period of life spent in good health. Their business model is centered around the creation and distribution of these therapies, with a focus on accessibility for patients.

Source: Dealroom company data

At a glance

Status
Operational
Employees
30
Open positions
4
Dealroom signal
74.4/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, Longevity, DT and LS, science-based
Client focus
B2B
Investment activity
7 companies, latest Oct 2022
Capital deployed
$268M
Preferred round
SERIES B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANTOther financing Feb 2026 $0 — Advanced Research Projects Agency for Health - ARPA-H ↗
LATE VCOther financing Jun 2023 $0 — FJ Labs · SV Pacific Ventures —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Cambrian BioPharma website traffic

Latest recorded traffic for Cambrian BioPharma is 5.4K monthly website visits, up 45.9% over the last three months. Cambrian BioPharma's team grew 7.1% over the past year.

Latest monthly visits5.4K 3-month web change+45.9% 1-year team growth+7.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Cambrian BioPharma in the New York City ecosystem

Live from Dealroom

The Cambrian BioPharma office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Advanced Research Projects Agency for Health - ARPA-H

Series A3 investors entered at this stage

  • Future Ventures
  • Apeiron Investment Group
  • Korify Capital

Series B and later5 investors entered at this stage

  • Anthos Capital
  • Moore Capital
  • SALT Fund
  • FJ Labs
  • SV Pacific Ventures
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States80%
🇬🇧 United Kingdom10%
🇭🇰 Hong Kong5%
🇦🇪 United Arab Emirates5%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cambrian BioPharma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cambrian BioPharma’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.